Navigation Links
Indian Australian Doctor Charged for Performing Illegal Abortion

An Indian Australian doctor has been found guilty of performing an illegal abortion but was cleared of a charge of manslaughter of a premature baby.//

Dr. Suman Sood was charged with manslaughter in November 2005 for allegedly failing to follow the procedures that make abortion legal in the state of New South Wales (NSW).

Reports here said the decision was reached by a jury of three men and eight women Wednesday after about 16 hours of deliberation about a series of complex medical and legal questions. The doctor now faces a maximum 10-year jail term.

Sood, 56, is the first doctor in NSW since 1971 to be tried over an abortion case. She was charged with giving a 20-year-old woman, who was about 23 weeks pregnant, an abortion drug at her clinic in Fairfeld, southwest of Sydney, in May 2002.

The doctor then asked the patient to come back the next day. But the latter didn't make it, delivering a baby boy in a toilet. The baby survived for about four hours.

Under NSW laws, abortions are illegal unless a doctor forms the honest, genuine and reasonable belief the abortion is necessary to protect the woman from serious danger to her life or her physical or mental health.

According to a report in the Sydney Morning Herald, crown prosecutor Mark Tedeschi argued that Sood had performed a dangerous and illegal act by administering the abortion drug, therefore being guilty of manslaughter.

But defence barrister Philip Boulten said that the patient could have had the miscarriage because her placenta - an ephemeral organ present only during gestation - was abnormal, or because she had a thyroid disease. Medical experts told the court both these conditions could induce labour.

On her part, Sood had told a Medical Board hearing that she had only given a painkiller to the patient and not an abortion drug.

Following the jury's decision, the Supreme Court was to decide later
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:7/18/2008)...wswire/ -- In the last ten years over 360,children... average of 36,per year, according to a study by M...ces., (See video from General Motors (NYSE: GM...y=35362 ) Hyperthermia is the overheating of the ...s a car can become for a small child in just a few...
(Date:7/18/2008)...uly 18 /PRNewswire-USNewswire/ -- Two consumer,gro...controversial patent,on human embryonic stem cells...(WARF)., Consumer Watchdog, formerly The Foundati...c Patent Foundation appealed to the U.S. Patent,Of... examiner narrowed,WARF,s patent after the two gro...
(Date:7/18/2008)... New research led by a Michigan State University ...rweight workers are lazier, more emotionally unsta...l weight" colleagues. , With the findings, emplo...based stereotypes when it comes to hiring, promoti...or of human resource management, and two colleague...
(Date:7/18/2008)...Newswire/ -- Highmark Blue Cross Blue Shield,Unit...s will join forces to,promote healthy smiles and l...and continuing until 3 p.m., tomorrow, July 19, a ...al screenings, restorations and sealants,for those...ived much less attention in,American culture than ...
Breaking Medicine News(10 mins):Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:Studies refute common stereotypes about obese workers 2Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2
...students gathered for a live chat with Indian Amer...xciting to view her as she spoke from her zero-gra...ds and necklace floating loosely, a scientific fac...fore. It was equally thrilling to be able to see ...
...en have you relied on your instincts or ‘gut-feel’...about time you do, because a recent study has rein...reliable beacon. A study conducted by the Unive...e in the journal, Current Biology, has shown the w...
...be still far from reality, but the very idea is bo...d the possibility of administering insulin orally/...sulin is given via injections or via inhalation li...ists from Taiwan’s National Tsing Hua University h...
...ton – The last ten years have witnessed a surge in...rtray//. The data shows that the number of surger... 64 age group and by 726 percent among patients be...res which are clubbed under the technical name, ba...
Other Medicine News:Health News:Indian Students Thrilled to Talk to Sunita Williams 2
(Date:7/16/2008)... of men rank discomfort as #1 reason to avoid disc...to heart disease, INDIANAPOLIS, July 16 /PRNewswi...2 percent of men with erectile dysfunction (ED) su...h conditions, such as heart,disease and diabetes, ...on,with their doctors. The survey, conducted by Ip...
(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCS... -- Raptor,Pharmaceuticals Corp. ("Raptor" or the ...nced the execution of a collaboration agreement (t... San Diego ("UCSD") to,include a Phase 2a clinical...f cysteamine bitartrate ("Cysteamine") in adolesce...
(Date:7/15/2008)... July 15 /PRNewswire-USNewswire/ -- A man sufferin...ian Hospital of Dallas ER and was,eventually treat... cardiac,catheterization lab in 28 minutes. The pr...ventional cardiologist at Presbyterian, involved u...ery and illustrates the,importance of providing tr...
(Date:7/15/2008)...- Company Reports Favorable Phase 1 RX-3341 Result...b-X Pharmaceuticals, Inc.,("Rib-X" or the "Company...covery and development of novel antibiotics for th...day announced the initiation of a Phase,2 clinical...und RX-3341 in,the treatment of complicated skin a...
Breaking Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Record 'Door-to-Balloon' Time at Presbyterian Hospital of Dallas 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3USP announces 2008 summer internship program participants 17031 1USP announces 2008 summer internship program participants 17031 2More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 1More Than 350 Events Today in Recognition of First National Healthcare Decisions Day 17030 2Aflac Incorporated To Release First Quarter Results on April 23 2008 17028 1Aflac Incorporated To Release First Quarter Results on April 23 2008 17028 2Torchmark Corporation Reports First Quarter 2008 Results 17026 1Torchmark Corporation Reports First Quarter 2008 Results 17026 2Torchmark Corporation Reports First Quarter 2008 Results 17026 3Torchmark Corporation Reports First Quarter 2008 Results 17026 4Torchmark Corporation Reports First Quarter 2008 Results 17026 5Torchmark Corporation Reports First Quarter 2008 Results 17026 6Torchmark Corporation Reports First Quarter 2008 Results 17026 7Torchmark Corporation Reports First Quarter 2008 Results 17026 8Torchmark Corporation Reports First Quarter 2008 Results 17026 9
... /PRNewswire-FirstCall/ -,MIGENIX Inc. , a clinica... will make a presentation of results from a recent...ee April 11, 2007,press release) in a non-responde...W) 2007 being held in Washington, DC May 19-24,20...atitis,Investigative Unit (VHIU) at the Health Sci...
...swire-FirstCall/ -- A total,of 20 oral and poster ...ough,s hepatitis products, including PEGINTRON(TM)..., USP) combination,therapy for chronic hepatitis C... 503034), the company,s investigational oral HCV,p...evelopment, will,be presented by leading researche...
Other Medicine Technology:Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 2Migenix to Present Celgosivir Phase II Hepatitis C Results at,Digestive Disease Week 2007 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
Each handle is designed to fit a specific trephine size.
Each handle is designed to fit a specific trephine size.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Medicine Products: